Report Overview:
Multi-ingredient Codeine refers to pharmaceutical drugs that contain codeine in combination with other ingredients. These drugs are commonly used for pain relief, cough suppression, and other medical applications. Codeine, an opioid analgesic, is often combined with non-opioid analgesics like acetaminophen or ibuprofen to enhance its efficacy and reduce potential misuse.
Market Value:
The global Multi-ingredient Codeine market was valued at USD 193.80 million in 2024 and is projected to reach USD 311.23 million by 2032, growing at a CAGR of 6.10% during the forecast period. CAGR of 6.10% (2025 – 2032)
By Types:
By Applications: Narcotic Analgesic
Antitussive
Key players include:
• Taiji
• Mallinckrodt
• TEVA
• Johnson & Johnson
• Medreich
• Sanofi Aventis
• Cipla
• Hikma
• Including or Excluding key companies relevant to your analysis.
